Sunshine Provision Retained In Opioids Bill Compromise

27 Sep 2018

• By Sue Darcey

Congressional negotiators knitting together US Senate and House versions of opioids legislation retained a “sunshine” provision opposed by industry that would expand the types of health-care professionals for whom device and drug manufacturers must report to the federal Open Payments database.

A provision that expands the types of health-care providers that device companies need to report on to the Open Payments database was retained in a House-Senate compromise on opioids legislation released Sept. 26. Device manufacturers had argued that the provision should only pertain to pharmaceutical companies.

“The goal of the provision is to curb opioid prescribing, and devices are wholly separate from opioids,” AdvaMed CEO Scott...